Evidence map›Paper›PMID 42640566›Full record

ArticleRheumatology (Oxford, England)2026

Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles and patient-reported outcomes.

Praggya Yaadav, Lekshmi Minikumari Rahulan, Suhana Hussain, Manali Sarkar, Vincenzo Venerito, Vahed Maroufy, Maria R Pellico, Anne-Marie Russell, Sreoshy Saha, Elena Nikiphorou and 12 more

Abstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Praggya YaadavMaharashtra Institute of Medical Sciences and Research, Latur, Maharashtra, India.ORCID 0000-0003-4372-2540
Lekshmi Minikumari RahulanDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.ORCID 0009-0003-5921-3684
Suhana HussainMahatma Gandhi Medical College and Hospital, Jaipur, India.ORCID 0009-0007-3072-0163
Manali SarkarSir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India.ORCID 0000-0002-6732-2907
Vincenzo VeneritoUniversity of Bari, Department of Precision and Regenerative Medicine and Ionian Area, Rheumatology Unit, Bari, Italy.ORCID 0000-0002-2573-5930
Vahed MaroufyDepartment of Biostatistics and Data Science, School of Public Health, The University of Texas Health Center at Houston School of Public Health, Austin, TX, USA.ORCID 0000-0002-6653-7586
Maria R PellicoDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID 0009-0004-1921-7370
Anne-Marie RussellSchool of Medicine and Health, University of Birmingham, Birmingham, UK.ORCID 0000-0002-0468-3537
Sreoshy SahaMymensingh Medical College Hospital, Mymensingh, Bangladesh.ORCID 0000-0001-6745-9770
Elena NikiphorouCentre for Rheumatic Diseases, King's College London, London, UK.ORCID 0000-0001-6847-3726
Ioannis ParodisDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM), Stockholm, Sweden.ORCID 0000-0002-4875-5395
Vidya S LimayeRheumatology Department, Royal Adelaide Hospital, Adelaide, SA, Australia.ORCID 0000-0002-8142-9532
Dimitri L F da SilvaDepartment of Dermatology, University Santo Amaro, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0003-0869-9330
Samuel K ShinjoDivision of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.ORCID 0000-0002-3682-4517
Jessica DayDepartment of Rheumatology, Royal Melbourne Hospital, Parkville, VIC, Australia.ORCID 0000-0001-8528-4361
Aviya L LevyRady Children's Hospital, University of California San Diego, San Diego, CA, USA.ORCID 0000-0002-1309-6481
Karen ChengPatient Research Partner/Volunteer, EULAR PARE, Zurich, Switzerland.ORCID 0009-0004-3850-8480
Laura AndreoliRheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy.ORCID 0000-0002-9107-3218
Jasmine PariharAll India Institute of Medical Science, New Delhi, and National Cancer Institute, Jhajjar, India.ORCID 0000-0002-5545-4304
COVAD Study Group
Vikas AgarwalDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.ORCID 0000-0002-4508-1233
Latika GuptaDepartment of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.ORCID 0000-0003-2753-2990

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSelf-efficacy (SE) is central to chronic disease self-management but remains poorly characterized in idiopathic inflammatory myopathies (IIMs). We aimed to identify factors associated with SE, characterize SE profiles and examine associations with patient-reported outcomes (PROs) in IIMs.

methodsCross-sectional data from 5802 participants across IIMs, other rheumatic diseases (RMDs) and non-rheumatic autoimmune diseases (nRAIDs) were analysed. SE was measured using the Self-Efficacy for Managing Chronic Disease (SEMCD) scale. Hierarchical regression identified factors independently associated with SE, and k-means clustering defined SE health profiles. Associations with PROs were examined in a separate multivariable model.

resultsIIM patients had lower SE (median SEMCD 5.3) than those with RMDs (5.8) and nRAIDs (6.5), with confidence lowest for managing fatigue and physical discomfort. In the fully adjusted integrated model (R² = 0.222), mental health comorbidity (B = -0.898) and financial difficulty (B = -0.734) were most strongly associated with lower SE, while regular exercise (B = 0.770) and family support (B = 0.150) were associated with higher SE. The PRO model explained 48.3% of SE variance (R² = 0.483); resilience was the strongest positive association, while fatigue and pain were negatively associated. Four SE health profiles were identified, including a clinically distinctive resilient-despite-burden subgroup (24%) with high symptom burden but preserved SE and mental health. Higher SE was associated with better physical and mental health, greater resilience and life satisfaction, and lower fatigue, pain and loneliness (all P < 0.001).

conclusionSE in IIMs is associated with modifiable socioeconomic and psychological factors and with better health outcomes. Profile-based stratification may help identify vulnerable subgroups and guide targeted interventions.

Indexed as

MyositisPatient Reported Outcome MeasuresSelf EfficacyAdultAgedCross-Sectional StudiesFatigueFemaleHumansMaleMiddle AgedQuality of LifeRheumatic DiseasesSelf Carecluster analysisidiopathic inflammatory myopathiesmental health comorbiditymyositispatient-reported outcomesself-efficacyself-management

Identifiers

PMID42640566
PMCPMC13616047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.